ProtoPulse · CNAS therapeutic protocols
Data updated 19 Oct 2026, 22:37 · printed from ProtoPulse

OCTREOTIDUM

Active substance (INN) · ATC H01CB02 · 8 products authorised in Romania

◀ Back

Protocols it appears in

As a medicine of the protocol (in the title) or only mentioned in the text

Code	Protocol	Status	Role	Sublist	GP
A10AE06	INSULINUM DEGLUDEC	In force	mentioned in the text	C2-P5	NO
H005E	PROTOCOL TERAPEUTIC ÎN ACROMEGALIE ŞI GIGANTISM	In force	mentioned in the text	C1-G22	YES
H006C	TUMORI NEUROENDOCRINE - TRATAMENT CU ANALOGI DE SOMATOSTATINĂ	In force	mentioned in the text	C1-G22	NO

Authorised brand products (ANMDM)

The Romanian register of medicines for human use, updated daily

Brand name	Form	Strength	Holder	ATC	Rx
OCTREOTIDA ROMPHARM 0,1 mg/ml	SOL INJ./PERF.	0,1mg/ml	ROMPHARM COMPANY S.R.L. - ROMANIA	H01CB02	PR
OCTREOTIDA TEVA 10 mg	PULB. SI SOLV. PT. SUSP. INJ. CU ELIB. PREL.	10mg	TEVA PHARMACEUTICALS S.R.L. - ROMANIA	H01CB02	PR
OCTREOTIDA TEVA 20 mg	PULB. SI SOLV. PT. SUSP. INJ. CU ELIB. PREL.	20mg	TEVA PHARMACEUTICALS S.R.L. - ROMANIA	H01CB02	PR
OCTREOTIDA TEVA 30 mg	PULB. SI SOLV. PT. SUSP. INJ. CU ELIB. PREL.	30mg	TEVA PHARMACEUTICALS S.R.L. - ROMANIA	H01CB02	PR
SANDOSTATIN 100 micrograme/ml	SOL. INJ./PERF.	0,1mg/ml	NOVARTIS EUROPHARM LIMITED - IRLANDA	H01CB02	PR
SANDOSTATIN LAR 10 mg	PULB. SI SOLV. PT. SUSP. INJ.	10mg	NOVARTIS EUROPHARM LIMITED - IRLANDA	H01CB02	PR
SANDOSTATIN LAR 20 mg	PULB. SI SOLV. PT. SUSP. INJ.	20mg	NOVARTIS EUROPHARM LIMITED - IRLANDA	H01CB02	PR
SANDOSTATIN LAR 30 mg	PULB. SI SOLV. PT. SUSP. INJ.	30mg	NOVARTIS EUROPHARM LIMITED - IRLANDA	H01CB02	PR

Data extracted automatically from the documents published by CNAS (cnas.ro/protocoale-terapeutice) and from the ANMDM medicines register. For information only; the official text (the Ministry of Health / CNAS orders published in the Official Gazette) prevails. Protocol names and texts are shown in Romanian, as published.